These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18212256)

  • 1. Potential influence of antisecretory therapy on the development of Candida-associated intraabdominal infection.
    Cat TB; Charash W; Hebert J; Marden BT; Corbett SM; Ahern J; Rebuck JA
    Ann Pharmacother; 2008 Feb; 42(2):185-91. PubMed ID: 18212256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection.
    Howell MD; Novack V; Grgurich P; Soulliard D; Novack L; Pencina M; Talmor D
    Arch Intern Med; 2010 May; 170(9):784-90. PubMed ID: 20458086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients.
    Aseeri M; Schroeder T; Kramer J; Zackula R
    Am J Gastroenterol; 2008 Sep; 103(9):2308-13. PubMed ID: 18702653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthcare costs of GERD and acid-related conditions in pediatric patients, with comparison between histamine-2 receptor antagonists and proton pump inhibitors.
    Kothari S; Nelson SP; Wu EQ; Beaulieu N; McHale JM; Dabbous OH
    Curr Med Res Opin; 2009 Nov; 25(11):2703-9. PubMed ID: 19775195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp.
    Playford EG; Marriott D; Nguyen Q; Chen S; Ellis D; Slavin M; Sorrell TC
    Crit Care Med; 2008 Jul; 36(7):2034-9. PubMed ID: 18552700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton Pump Inhibitors and the Risk for Hospital-Acquired Clostridium difficile Infection.
    Barletta JF; El-Ibiary SY; Davis LE; Nguyen B; Raney CR
    Mayo Clin Proc; 2013 Oct; 88(10):1085-90. PubMed ID: 24012413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of fluconazole administration on outcomes in critically ill patients.
    Garrelts JC; Schroeder TR; Harrison PB
    Ann Pharmacother; 2004 Oct; 38(10):1588-92. PubMed ID: 15340132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for nosocomial candiduria due to Candida glabrata and Candida albicans.
    Harris AD; Castro J; Sheppard DC; Carmeli Y; Samore MH
    Clin Infect Dis; 1999 Oct; 29(4):926-8. PubMed ID: 10589912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.
    Bajaj JS; Zadvornova Y; Heuman DM; Hafeezullah M; Hoffmann RG; Sanyal AJ; Saeian K
    Am J Gastroenterol; 2009 May; 104(5):1130-4. PubMed ID: 19337238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do proton pump inhibitors increase the incidence of nosocomial pneumonia and related infectious complications when compared with histamine-2 receptor antagonists in critically ill trauma patients?
    Mallow S; Rebuck JA; Osler T; Ahern J; Healey MA; Rogers FB
    Curr Surg; 2004; 61(5):452-8. PubMed ID: 15475094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough.
    Mainie I; Tutuian R; Castell DO
    J Clin Gastroenterol; 2008 Jul; 42(6):676-9. PubMed ID: 18496394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome.
    Dimopoulos G; Ntziora F; Rachiotis G; Armaganidis A; Falagas ME
    Anesth Analg; 2008 Feb; 106(2):523-9, table of contents. PubMed ID: 18227310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial.
    Magill SS; Swoboda SM; Shields CE; Colantuoni EA; Fothergill AW; Merz WG; Lipsett PA; Hendrix CW
    Ann Surg; 2009 Apr; 249(4):657-65. PubMed ID: 19300221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of H2-receptor antagonist and proton pump inhibitor on microbial proliferation in the stomach.
    Wang K; Lin HJ; Perng CL; Tseng GY; Yu KW; Chang FY; Lee SD
    Hepatogastroenterology; 2004; 51(59):1540-3. PubMed ID: 15362796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population.
    Agréus L; Storskrubb T; Aro P; Ronkainen J; Talley NJ; Sipponen P
    Scand J Gastroenterol; 2009; 44(5):564-70. PubMed ID: 19263272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of the risk factors in nosocomial urinary tract infections and effect of urinary catheter use on distribution of the causative agents].
    Erben N; Alpat SN; Kartal ED; Ozgüneş I; Usluer G
    Mikrobiyol Bul; 2009 Jan; 43(1):77-82. PubMed ID: 19334383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
    Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
    Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histamine 2 receptor antagonists vs intravenous proton pump inhibitors in a pediatric intensive care unit: a comparison of gastric pH.
    Tofil NM; Benner KW; Fuller MP; Winkler MK
    J Crit Care; 2008 Sep; 23(3):416-21. PubMed ID: 18725049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of risk factors and outcome among outpatient-acquired and nosocomial candidaemia.
    Pasqualotto AC; Nedel WL; Machado TS; Severo LC
    J Hosp Infect; 2005 Jun; 60(2):129-34. PubMed ID: 15866011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community-onset candidemia at a university hospital, 1995-2005.
    Kung HC; Wang JL; Chang SC; Wang JT; Sun HY; Hsueh PR; Chen YC
    J Microbiol Immunol Infect; 2007 Aug; 40(4):355-63. PubMed ID: 17712471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.